Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
AZZ has now reported its fiscal second-quarter results, and the week's most interesting development is not what happened on the earnings call but who showed up to rate the stock afterwards.
Barclays initiated coverage on October 14 with an Equal-Weight rating and a $140 price target, landing almost exactly where the stock trades. That is a notably cautious entry point from a bellwether firm: $140 implies virtually no upside from the current $136.71 close, against a Street consensus target of $161.60. The gap between Barclays and the broader analyst community is worth noting. B. Riley Securities holds a Buy with a $170 target. Evercore ISI carries an Outperform at $152. Wells Fargo, which downgraded to Equal-Weight back in March, sits at $144. The consensus remains "hold" across five ratings, but the dispersion between the bears and the bulls is wide. Those who like the stock see roughly 20% to 25% upside. Those who don't see the current price as roughly fair. With the stock having climbed around 28% year-to-date before this week's 3.4% pullback, the valuation debate is live. The PE sits near 17.9 times and EV/EBITDA around 11.2 times, both of which have drifted slightly lower over the past week as the share price has eased.
Positioning around the print was, as flagged in the prior note, notably relaxed. Short interest has continued its retreat, edging up just 1.6% on the day but still down roughly 14% on the week to 2.76% of the free float. That follows a sharp drop earlier in October when bears cut around 140,000 shares from their position between October 7 and October 9. The borrow market remains completely unconstricted: availability is running at nearly 5,900% of short interest, meaning there are roughly 59 shares available to lend for every one currently borrowed. Cost to borrow, while up 36% on the week in percentage-change terms, remains at 0.48%, barely above zero in practical terms. There is no short squeeze tension here. The ORTEX short score has eased to 34.4, its lowest reading in the recent window, consistent with the view that bearish conviction on AZZ is low. Options traders are similarly relaxed, with the put/call ratio at 0.39, barely above its 20-day average of 0.37 and well within the lower half of its 52-week range.
One aspect of the ownership picture is worth carrying forward. Several large passive holders have been trimming around the 5% disclosure threshold. Capital International filed in May showing its stake had fallen from 6.5% to 4.8%. FMR LLC disclosed in August that it had dropped from 6.0% to 4.8%. T. Rowe Price filed in mid-August showing a move from 5.9% to 4.6%. All three have crossed below the level where they would be required to file again if they continued selling, so those stakes should be treated as "at last disclosed" rather than current. On the other side, Invesco added over 525,000 shares as of September 30, a material move that lifted its holding to around 1.8% of shares. BlackRock and T. Rowe Price both added modestly in the same period. The institutional picture is broadly one of index-weight maintenance rather than active conviction building, though Invesco's move stands out.
The alt-data signal worth mentioning is in retail attention. Wikipedia page views for AZZ spiked to a z-score of 6.7 against its own trailing 90 days, as of late September. That is a retail attention reading, not a revenue indicator, but it suggests the earnings event generated a meaningful spike in public interest well above the company's own historical baseline.
With the print now behind it and the next earnings event scheduled for January 8, the focus shifts to how management's commentary on infrastructure demand and metal coatings volumes translates into the coming quarter. The spread between Barclays at $140 and B. Riley at $170 maps almost exactly the range of outcomes the market is pricing. Whether the stock can close that gap will depend on whether near-term results validate the more constructive end of that range.
See the live data behind this article on ORTEX.
Open AZZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.